Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Sep 15, 2022
Date Accepted: Dec 1, 2022

The final, peer-reviewed published version of this preprint can be found here:

The Effect of Implementation of Guideline Order Bundles Into a General Admission Order Set on Clinical Practice Guideline Adoption: Quasi-Experimental Study

Mrosak J, Kandaswamy S, Stokes C, Roth D, Gorbatkin J, Dave I, Gillespie S, Orenstein E

The Effect of Implementation of Guideline Order Bundles Into a General Admission Order Set on Clinical Practice Guideline Adoption: Quasi-Experimental Study

JMIR Med Inform 2023;11:e42736

DOI: 10.2196/42736

PMID: 36943348

PMCID: 10131941

Effect of Implementation of Guideline Order Bundles into a General Admission Order Set on Clinical Practice Guideline Adoption: Quasi-Experimental Design

  • Justine Mrosak; 
  • Swaminathan Kandaswamy; 
  • Claire Stokes; 
  • David Roth; 
  • Jenna Gorbatkin; 
  • Ishaan Dave; 
  • Scott Gillespie; 
  • Evan Orenstein

ABSTRACT

Background:

Clinical practice guidelines (CPGs) help disseminate evidence-based practices to improve patient outcomes. Clinical decision support through disease-specific order sets can improve adoption of CPGs. However, many patients eligible for CPGs are not managed in concordance with CPG recommendations.

Objective:

To determine how integrating disease-specific order groups into a common general admission order set influences adoption of clinical practice guideline CPG-specific order bundles for patients meeting CPG inclusion criteria admitted to the general pediatrics service.

Methods:

We integrated order bundles for asthma, heavy menstrual bleeding, musculoskeletal infection, migraine, and pneumonia into a common general pediatrics order set. We compared order bundle usage rates for eligible encounters pre- and post-implementation at both an intervention and non-intervention site for integrated CPGs. We also assessed order bundle adoption for non-integrated CPGs including bronchiolitis, acute gastroenteritis, and croup. In a post-hoc analysis, among encounters without order bundle use, we compared the frequency of diagnostic uncertainty at the time of admission pre- and post-intervention.

Results:

CPG order bundle usage rates for incorporated CPGs increased by +9.8% (from 73.5% to 83.3%) at the intervention site and by +5.1% (66.3% to 71.4%) at the non-intervention site. Order bundle adoption for non-integrated CPGs decreased from 84.0% to 68.5%, driven primarily by decreases in bronchiolitis order bundle adoption in the setting of the COVID-19 pandemic. Diagnostic uncertainty was more common in admissions without CPG order bundle use after implementation (12.3% vs. 23.4%).

Conclusions:

The integration of CPG-specific order bundles into a general admission order set improved overall CPG adoption. However, integrating only some CPGs may reduce adoption of order bundles for excluded CPGs. Diagnostic uncertainty at the time of admission is likely an under-recognized barrier to guideline adherence that is not addressed by an integrated admission order set.


 Citation

Please cite as:

Mrosak J, Kandaswamy S, Stokes C, Roth D, Gorbatkin J, Dave I, Gillespie S, Orenstein E

The Effect of Implementation of Guideline Order Bundles Into a General Admission Order Set on Clinical Practice Guideline Adoption: Quasi-Experimental Study

JMIR Med Inform 2023;11:e42736

DOI: 10.2196/42736

PMID: 36943348

PMCID: 10131941

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.